Research output: Contribution to journal › Journal article › Research › peer-review
}
TY - JOUR
T1 - Is the SPINK1 variant p.N34S overrepresented in patients with acute pancreatitis?
AU - Jøergensen, Maiken Thyregod
AU - Brusgaard, Klaus
AU - Novovic, Srdan
AU - Andersen, Anders Møller
AU - Hansen, Mark Berner
AU - Gerdes, Anne-Marie
AU - de Muckadell, Ove Bent Schaffalitzky
N1 - Author(s): Joergensen, MT (Joergensen, Maiken Thyregod)[ 1 ] ; Brusgaard, K (Brusgaard, Klaus)[ 2 ] ; Novovic, S (Novovic, Srdan)[ 4 ] ; Andersen, AM (Andersen, Anders Moller)[ 4 ] ; Hansen, MB (Hansen, Mark Berner)[ 4,5 ] ; Gerdes, AM (Gerdes, Anne-Marie)[ 2,3 ] ; de Muckadell, OBS (de Muckadell, Ove Bent Schaffalitzky)[ 1 ] 1 ] Univ So Denmark, Dept Med Gastroenterol S, Odense Univ Hosp, DK-5000 Odense C, Denmark [ 2 ] Univ So Denmark, Dept Clin Genet, Odense Univ Hosp, DK-5000 Odense C, Denmark [ 3 ] Univ Copenhagen, Rigshosp, Dept Clin Genet, DK-2100 Copenhagen, Denmark [ 4 ] Univ Copenhagen, Bispebjerg Hosp, Dept Surg K, Copenhagen, Denmark [ 5 ] AstraZeneca Res & Dev, Molndal, Sweden
PY - 2012
Y1 - 2012
N2 - Serine Protease Inhibitor Kazal type 1 (SPINK1) protects against premature intracellular activation of trypsinogen and development of acute pancreatitis. Our aim was to determine the prevalence of SPINK1 mutations (a) in unselected patients with first-time acute pancreatitis and (b) in the Danish background population (c) in a meta-analysis to combine the results with findings in similar investigations worldwide and (d) to evaluate whether patients with SPINK1 mutations had a more severe clinical course.
AB - Serine Protease Inhibitor Kazal type 1 (SPINK1) protects against premature intracellular activation of trypsinogen and development of acute pancreatitis. Our aim was to determine the prevalence of SPINK1 mutations (a) in unselected patients with first-time acute pancreatitis and (b) in the Danish background population (c) in a meta-analysis to combine the results with findings in similar investigations worldwide and (d) to evaluate whether patients with SPINK1 mutations had a more severe clinical course.
KW - Acute Disease
KW - Aged
KW - Biological Markers
KW - C-Reactive Protein
KW - Carrier Proteins
KW - Case-Control Studies
KW - Denmark
KW - Female
KW - Humans
KW - Male
KW - Middle Aged
KW - Mutation
KW - Pancreatitis
KW - Prognosis
KW - Prospective Studies
U2 - 10.1097/MEG.0b013e32834ee5e2
DO - 10.1097/MEG.0b013e32834ee5e2
M3 - Journal article
C2 - 22228370
VL - 24
SP - 309
EP - 315
JO - European Journal of Gastroenterology and Hepatology
JF - European Journal of Gastroenterology and Hepatology
SN - 0954-691X
IS - 3
ER -
ID: 36820247